Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Health Care

57.05
-0.1900-0.33%
Post-market: 57.050.00000.00%19:30 EDT
Volume:22.10K
Turnover:1.26M
Market Cap:92.42M
PE:- -
High:57.19
Open:57.03
Low:56.45
Close:57.24
52wk High:64.60
52wk Low:42.76
Shares:1.62M
Float Shares:1.62M
Volume Ratio:1.13
T/O Rate:1.36%
Dividend:0.63
Dividend Rate:1.11%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Offer Insights on Healthcare Companies: Merck & Company (MRK), Celldex (CLDX) and Inventiva (IVA)

TIPRANKS
·
Sep 23

Kimberly-Clark Offers Remedies in Bid for EU Approval of Kenvue Deal

Reuters
·
Sep 23

Novo Nordisk Open to Direct New York Listing, CEO Doustdar Tells FT

Reuters
·
Sep 23

Merck & Co Inc : TD Cowen Raises Target Price to $155 from $137

THOMSON REUTERS
·
Sep 23

Medtronic PLC Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
·
Sep 23

Want to Bet on Risky, High-Beta Stocks? Why You Should Wait for This Week in October.

Dow Jones
·
Sep 23

Wall Street Analysts Are Neutral on Top Healthcare Picks

TIPRANKS
·
Sep 23

AbbVie Tells USTR Germany Drug Pricing Reforms Cut Innovative Medicine Value by Nearly 54%

Reuters
·
Sep 23

Eli Lilly Price Target Maintained with a $1250.00/Share by TD Cowen

Dow Jones
·
Sep 22

Viking Therapeutics Stock Surges 35%. It Could Challenge Lilly and Novo's Obesity Empire

Dow Jones
·
Sep 22

Analysts Have Conflicting Sentiments on These Healthcare Companies: Pyxis Oncology (PYXS), Moderna (MRNA) and Eli Lilly & Co (LLY)

TIPRANKS
·
Sep 22

Weight-Loss Drug Developers Line up to Tap Lucrative Market as Competition Heats Up

Reuters
·
Sep 22

Viking Therapeutics Stock Surges 36%. it Could Challenge Lilly and Novo's Obesity Empire.

Dow Jones
·
Sep 22

DePuy Synthes Showcases Next-Generation Trauma Innovations at OTA 2026

Reuters
·
Sep 22

J&J DePuy Synthes to Showcase Next-Generation Trauma Devices at Orthopaedic Trauma Association Annual Meeting

Reuters
·
Sep 22

Merck Gets FDA Label Update for WINREVAIR Based on HYPERION Trial

MT Newswires Live
·
Sep 22

Merck says FDA approves update for U.S. product label for Winrevair

TIPRANKS
·
Sep 22

U.S. FDA Approves Update to the Label for Winrevair to Include Data from the Phase 3 Hyperion Trial Evaluating Adults Recently Diagnosed with Pulmonary Arterial Hypertension

Reuters
·
Sep 22

Merck Says Phase 3 Hyperion Trial Shows Winrevair Cuts PAH Clinical Worsening Risk 76%

Reuters
·
Sep 22

AbbVie: EC approves Rinvoq to treat polyarticular juvenile idiopathic arthritis

TIPRANKS
·
Sep 22